In this Issue:
CRC/dysplasia risk in IBD
Vedolizumab induction and maintenance for IBD
Nonanaemic iron deficiency and fatigue in IBD
Mesalazine and probiotics in SUDD
Centralised endoscopy in mesalazine for UC trial
MRE for assessing CD response to therapy
IBD nurse improves service delivery
Vitamin D and cancer risk in IBD
Malignancies in IBD
Relapse predictors in infliximab-treated UC
Please login below to download this issue (PDF)